Serious bacterial infection in recently immunized young febrile infants

Academic Emergency Medicine

Volumn 16, Issue 12, 2009, Pages 1284-1289

  Wolff, Margaret ^a   Bachur, Richard ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Emergency medicine; Fever; Immunization; Infant; Serious bacterial infection; Vaccination

Indexed keywords

ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; FEVER; HUMAN; IMMUNIZATION; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; URINARY TRACT INFECTION;

ACUTE DISEASE; BACTERIAL INFECTIONS; BOSTON; COHORT STUDIES; COMORBIDITY; FEVER; HUMANS; IMMUNIZATION; INFANT; PREVALENCE; RISK; TIME FACTORS; URINARY TRACT INFECTIONS;

EID: 71549131641     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2009.00582.x     Document Type: Article

References (21)

1. Alpern ER, Stanley RM, Gorelick MH, et al. Epidemiology of a pediatric emergency medicine research network: the PECARN Core Data Project. Pediatr Emerg Care. 2006; 22:689-699
2. Slater M, Krug SE. Evaluation of the infant with fever without source: an evidence based approach. Emerg Med Clin North Am. 1999; 17:97-126. (Pubitemid 29147009)
3. Bonadio WA, Smith DS, Sabnis S. The clinical characteristics and infectious outcomes of febrile infants aged 8 to 12 weeks. Clin Pediatr (Phila). 1994; 33:95-99 (Pubitemid 24058578)
4. Bonadio WA. The history and physical assessments of the febrile infant. Pediatr Clin North Am. 1998; 45:65-77.
5. Baker MD, Avner JR, Bell LM. Failure of infant observation scales in detecting serious illness in febrile, 4- to 8-week-old infants. Pediatrics. 1990; 85:1040-1043
6. Jaskiewicz JA, McCarthy CA, Richardson AC, et al. Febrile infants at low risk for serious bacterial infection-an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics. 1994; 94:390-396
7. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med. 1993; 22:1198-1210
8. Dagan R, Powell KR, Hall CB, Menegus MA. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr. 1985; 107:855-860 (Pubitemid 16197090)
9. GlaxoSmithKline. PEDIARIX [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined]. Prescribing Information. Available at: http://us.gsk.com/products/ assets/us-pediarix.pdf. Accessed Sep 4, 2009.
10. CDC. Recommended childhood immunization schedule-United States, 2000. MMWR Morb Mortal Wkly Rep. 2000; 49:35-8, 47.
11. CDC. Recommended childhood immunization schedule-United States, 2001. MMWR Morb Mortal Wkly Rep. 2001; 50:7-10, 19.
12. CDC. Recommended immunization schedules for persons aged 0-18 years, United States, 2007. MMWR Morb Mortal Wkly Rep. 2007; 55:Q1-Q4.
13. Massachussetts Department of Public Health. Pediarix Combination Vaccine Clinical Advisory. Available at: http://www.mass.gov/Eeohhs2/docs/dph/cdc/ immunization/alerts-alerts-pediarix-ca-200407.rtf. Accessed Aug 25, 2009.
14. Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics. 2001; 108:311-316
15. Jaskiewicz JA, McCarthy CA. Evaluation and management of the febrile infant 60 days of age or younger. Pediatr Ann. 1993; 22:477-480
16. Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med. 1993; 329:1437-1441
17. Ali SS, Chandrashekar SR, Singh M, Bansal RK, Sharma DR, Arora D. A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine). Hum Vaccin. 2007; 3:116-120 (Pubitemid 47501029)
18. Lieu TA, Black SB, Ray GT, Martin KE, Shinefield HR, Weniger BG. The hidden costs of infant vaccination. Vaccine. 2000; 19:33-41.
19. Thompson LA, Irigoyen M, Matiz LA, LaRussa PS, Chen S, Chimkin F. The impact of DTaP-IPV-HB vaccine on use of health services for young infants. Pediatr Infect Dis J. 2006; 25:826-831
20. Evans RW. Complications of lumbar puncture. Neurol Clin. 1998; 16:83-105.
21. Levine DA, Platt SL, Dayan PS, et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics. 2004; 113:1728-1734 (Pubitemid 38697983)